51
|
Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012; 199:26-34. [PMID: 22733890 DOI: 10.2214/ajr.11.7750] [Citation(s) in RCA: 90] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE The purpose of this article is to prospectively determine the sensitivity of hepatobiliary phase gadoxetate disodium-enhanced MRI combined with standard MRI in differentiating focal nodular hyperplasia (FNH) from hepatocellular adenoma (HCA). SUBJECTS AND METHODS Patients suspected of having FNH or HCA larger than 2 cm underwent gadoxetate disodium-enhanced MRI. Standard MRI was evaluated separately from the additional hepatobiliary phase by two blinded radiologists. For the largest lesion in each patient, findings were compared with histologic diagnosis. Sensitivity, positive predictive value (PPV), and distinctive features were analyzed using McNemar and analysis of variance tests. RESULTS Fifty-two patients completed the study. Histologic diagnosis revealed 24 HCAs and 28 FNHs. Characterization on standard MRI was inconclusive in 40% (21/52) and conclusive in 60% (31/52) of lesions. The sensitivity of standard MRI for HCA was 50% (12/24) with a PPV of 100% (12/12). The sensitivity for FNH was 68% (19/28) with a PPV of 95% (18/19). After review of hepatobiliary phase, the sensitivity for HCA improved to 96% (23/24) with a PPV of 96% (23/24). The sensitivity for FNH improved to 96% (27/28) with a PPV of 96% (27/28). Features with significant predictive value for diagnosis in HCA included bleeding (p < 0.001), fat (p = 0.010), and glycogen (p = 0.024). The presence of a central scar was predictive for FNH (p < 0.001). CONCLUSION This study shows high sensitivity of gadoxetate disodium-enhanced MRI when standard series are combined with the hepatobiliary phase for differentiation of FNH and HCA in lesions larger than 2 cm.
Collapse
|
52
|
Hansen N, Weadock W, Morani A, Carlos R. Liver lesions discovered incidentally on ultrasound: evaluation of reader ability to characterize lesions on MRI without intravenous contrast. Acad Radiol 2012; 19:1087-93. [PMID: 22877986 DOI: 10.1016/j.acra.2012.06.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2012] [Revised: 06/15/2012] [Accepted: 06/18/2012] [Indexed: 10/28/2022]
Abstract
RATIONALE AND OBJECTIVES Liver lesions incidentally discovered on ultrasound (US) are often further evaluated with magnetic resonance imaging (MRI). The purpose of this study is to evaluate the added effectiveness of contrast-enhanced MRI, compared to noncontrast MRI, to correctly guide management of liver lesions incidentally identified on ultrasound in patients with low pretest probability of malignancy. We conducted the evaluation using a multireader study. MATERIALS AND METHODS Liver MRI studies ordered to evaluate incidental liver US lesions were selected for analysis. Patients with no prior history of cancer or chronic liver disease who had 2 years of clinical follow-up (72 patients) were selected to ensure low pretest probability of malignancy and adequate follow-up to establish proof of diagnosis. Fifty of these studies were randomly selected and analyzed by two abdominal radiologists. In the initial interpretation session, only nonenhanced images were reviewed; after 6 weeks, the complete exam including the contrast enhanced images were viewed. Differences in interpretation between the noncontrast and contrast enhanced reading sessions were assessed. RESULTS Sixty-nine patients (95.8%) had no abnormalities, benign masses, or hepatic steatosis accounting for the ultrasound findings. One patient was newly diagnosed with hereditary hemochromatosis, and 2 patients were newly diagnosed with metastatic disease. The most likely diagnosis changed for 15 of the lesions described by reader A, and 16 by reader B. The majority of these changes (26/31 lesions, 84%) were from one benign entity to another. Five of 31 (16%) of the changes involved that of a benign entity to a malignant one. Reader A recommended additional contrast enhanced imaging in 13/50 (26%) patients; reader B, 9/50 (18%) patients. After viewing the nonenhanced images, both readers recommended that all patients with eventual malignancies return for contrast administration and/or biopsy. After viewing the contrast-enhanced imaging, both readers accurately diagnosed all malignancies. Patient-based analysis receiver operating characteristic curves demonstrated no significant difference between the enhanced and noncontrast limbs of the study, and no significant difference between readers. CONCLUSION Most of the changes in lesion detection and characterization made after contrast administration were clinically insignificant. In the lesions in which clinically important differences were made, both radiologists recommended additional imaging or biopsy that would have eventually led to the correct diagnosis. None of the patients with malignancy was categorized as completely benign either on noncontrast or contrast-enhanced imaging. This supports the utility of initially performing a noncontrast examination in a population with a low pretest probability of malignancy, especially those in whom gadolinium administration is contraindicated.
Collapse
|
53
|
"Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma. HPB SURGERY : A WORLD JOURNAL OF HEPATIC, PANCREATIC AND BILIARY SURGERY 2012; 2012:891787. [PMID: 22927707 PMCID: PMC3423934 DOI: 10.1155/2012/891787] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/08/2012] [Revised: 04/20/2012] [Accepted: 05/05/2012] [Indexed: 12/15/2022]
Abstract
The continuous development of highly sensitive clinical imaging increased the detection of focal lesions of the liver. These accidentally detected liver tumors without liver-specific symptoms such as cholestasis have been named “incidentalomas.” Diagnostic tools such as sonography, computed tomography, or magnetic resonance imaging are used increasingly in asymptomatic individuals without defined suspected diagnoses in the setting of general prevention or followup after a history of malignancy. But despite continuous improvement of diagnostics, some doubt regarding the benign or malign behavior of a tumor remains. In case an asymptomatic hemangioma or FNH can be preoperatively detected with certainty, the indication for surgery must be very strict. In case of symptomatic liver lesions surgical resection should only be indicated with tumor-specific symptoms. In the remaining cases of benign lesions of the liver, a “watch and wait” strategy is recommended. In case of uncertain diagnosis, especially in patients with positive history of a malignant tumor or the suspected diagnosis of hepatocellular adenoma, surgical resection is indicated. Due to the continuous improvement of surgical techniques, liver resection should be done in the laparoscopic technique. Laparoscopic surgery has lower morbidity and shorter hospitalization than open technique.
Collapse
|
54
|
Gallotti A, D'Onofrio M, Romanini L, Cantisani V, Pozzi Mucelli R. Acoustic Radiation Force Impulse (ARFI) ultrasound imaging of solid focal liver lesions. Eur J Radiol 2012; 81:451-5. [PMID: 21330078 DOI: 10.1016/j.ejrad.2010.12.071] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2010] [Revised: 12/17/2010] [Accepted: 12/28/2010] [Indexed: 12/13/2022]
Abstract
OBJECTIVE The aim of this paper was to evaluate the application of ARFI ultrasound imaging and its potential value for characterizing focal solid liver lesions. MATERIALS AND METHODS In this multicentric prospective study, over a total non-consecutive period of four months, all patients underwent ARFI US examination. Two independent operators performed 5 measurements per each lesion and 2 measurements in the surrounding liver. According to the definitive diagnosis, a mean velocity value and standard deviations were obtained in each type of focal solid lesion, compared by using t-test, and the inter-operator evaluation was performed by using the Student's t-test. A comparison between the total mean values of each type of lesion and the mean value of the parenchyma was performed. RESULTS 40 lesions were evaluated and a total of 400 measurements were obtained. The lesions were: 6/40(15%) hepatocellular carcinomas, 7/40(17.5%) hemangiomas, 5/40(12.5%) adenomas, 9/40(22.5%) metastases and 13/40(32.5%) focal nodular hyperplasias. The total mean values obtained were: 2.17 m/s in HCCs, 2.30 m/s in hemangiomas, 1.25 m/s in adenomas, 2.87 m/s in metastases and 2.75 m/s in FNHs. The inter-operator evaluation resulted non-statistically different (p>0.05). A significant difference (p<0.05) was always found by comparing adenomas to the other lesions. 160 measurements were obtained in the surrounding parenchyma, with a no significant difference between values measured in adenomas and in the surrounding liver. CONCLUSIONS ARFI technology with Virtual Touch tissue quantification could non-invasively provide significant complementary information regarding the tissue stiffness, useful for the differential diagnosis of focal solid liver lesions.
Collapse
Affiliation(s)
- A Gallotti
- Department of Radiology, University Hospital G.B. Rossi, Piazzale L.A. Scuro 10, 37134, University of Verona, Verona, Italy
| | | | | | | | | |
Collapse
|
55
|
De Francesco V, Ierardi E, Stoppino G, Corsi F, D'Agnessa MR, Castriota M, Hassan C, Cianci F, Zullo A. Hepatic loss in a young patient: a very 'cold case'. Intern Emerg Med 2012; 7:49-52. [PMID: 21424907 DOI: 10.1007/s11739-011-0564-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2011] [Accepted: 03/10/2011] [Indexed: 10/18/2022]
Affiliation(s)
- Vincenzo De Francesco
- Section of Gastroenterology, Department of Medical Sciences, University of Foggia, Ospedali Riuniti, Foggia, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
56
|
Zhu XL, Chen P, Guo H, Zhang N, Hou WJ, Li XY, Xu Y. Contrast-enhanced ultrasound for the diagnosis of hepatic adenoma. J Int Med Res 2011; 39:920-8. [PMID: 21819725 DOI: 10.1177/147323001103900326] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Nine hepatic adenomas (HA) diagnosed by contrast-enhanced ultrasound (CEUS) among 123 liver lesions (89 patients) were evaluated retrospectively; five were confirmed through pathological diagnosis. Time-intensity curves (TIC), contrast medium arriving time (AT), peak time (PT) and retrogression time (RT) for HA were compared with 30 hepatocellular carcinomas (HCC) and six focal nodular hyperplasias (FNH). Significant differences existed between HA and poorly-differentiated HCC in AT, PT and RT, and between HA and well-differentiated HCC in AT. Differential diagnosis between HA and FNH was determined only through their different perfusion and arterial morphological features: HA showed typical perfusion characteristic of 'fast-in, slow-out', with a centripetal or mixed-filling pattern in the arterial phase, while FNH showed a centrifugal filling pattern. In conclusion, CEUS was helpful for identifying HA but it may be relatively difficult to distinguish between HA and some well-differentiated HCC or FNH.
Collapse
Affiliation(s)
- X L Zhu
- Ultrasound Department, Cancer Research Institute and Hospital of Tianjin Medical University, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin, China
| | | | | | | | | | | | | |
Collapse
|
57
|
Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, Merkle EM, Sakamoto M, Choi BI. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol 2011; 12:403-15. [PMID: 21852900 PMCID: PMC3150667 DOI: 10.3348/kjr.2011.12.4.403] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2010] [Accepted: 05/27/2011] [Indexed: 12/16/2022] Open
Abstract
This paper reports on issues relating to the optimal use of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging (Gd-EOB-DTPA MR imaging) together with the generation of consensus statements from a working group meeting, which was held in Seoul, Korea (2010). Gd-EOB-DTPA has been shown to improve the detection and characterization of liver lesions, and the information provided by the hepatobiliary phase is proving particularly useful in differential diagnoses and in the characterization of small lesions (around 1-1.5 cm). Discussion also focused on advances in the role of organic anion-transporting polypeptide 8 (OATP8) transporters. Gd-EOB-DTPA is also emerging as a promising tool for functional analysis, enabling the calculation of post-surgical liver function in the remaining segments. Updates to current algorithms were also discussed.
Collapse
Affiliation(s)
- Jeong Min Lee
- Department of Radiology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Korea.
| | | | | | | | | | | | | | | | | |
Collapse
|
58
|
Abstract
Malignant and nonmalignant disorders may affect the liver, causing signs and symptoms ranging from mild increases of liver tests to fulminant hepatic failure. This article discusses the most common hematologic and oncologic disorders and their effect on the liver. The section on nonmalignant hematologic disorders includes the anemias, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation, malaria, Banti syndrome, the porphyrias, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Malignant hematologic conditions include leukemias, lymphomas, and myeloproliferative disorders. Other conditions causing portal hypertension and hepatic metastases are also discussed. The most commonly encountered hepatic manifestations of hematologic and oncologic disorders are reviewed.
Collapse
Affiliation(s)
- Marvin M Singh
- Division of Gastroenterology and Hepatology, Scripps Clinic Torrey Pines, and The Scripps Research Institute, 10666 North Torrey Pines Road, N 203 La Jolla, CA 92037, USA
| | | |
Collapse
|
59
|
Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg 2011; 15:209-14. [PMID: 20549381 PMCID: PMC3023038 DOI: 10.1007/s11605-010-1248-1] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2010] [Accepted: 05/25/2010] [Indexed: 01/31/2023]
Abstract
INTRODUCTION Cavernous hemangiomas represent the most common benign primary hepatic neoplasm, often being incidentally detected. Although the majority of hepatic hemangiomas remain asymptomatic, symptomatic hepatic hemangiomas can present with abdominal pain, hemorrhage, biliary compression, or a consumptive coagulopathy. The optimal surgical management of symptomatic hepatic hemangiomas remains controversial, with resection, enucleation, and both deceased donor and living donor liver transplantation having been reported. CASE REPORT We report the case of a patient found to have a unique syndrome of multiorgan cavernous hemangiomatosis involving the liver, lung, omentum, and spleen without cutaneous involvement. Sixteen years following her initial diagnosis, the patient suffered from intra-abdominal hemorrhage due to her giant cavernous hepatic hemangioma. Evidence of continued bleeding, in the setting of Kasabach-Merritt Syndrome and worsening abdominal compartment syndrome, prompted MELD exemption listing. The patient subsequently underwent emergent liver transplantation without complication. CONCLUSION Although cavernous hemangiomas represent the most common benign primary hepatic neoplasm, hepatic hemangioma rupture remains a rare presentation in these patients. Management at a center with expertise in liver transplantation is warranted for those patients presenting with worsening DIC or hemorrhage, given the potential for rapid clinical decompensation.
Collapse
Affiliation(s)
- Parsia A. Vagefi
- Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143 USA
- Department of Surgery, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 USA
| | - Ingo Klein
- Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Bruce Gelb
- Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Bilal Hameed
- Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Stephen L. Moff
- Department of Gastroenterology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA 95051 USA
| | - Jeff P. Simko
- Department of Pathology, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Oren K. Fix
- Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Helge Eilers
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA 94143 USA
| | - John R. Feiner
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Nancy L. Ascher
- Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Chris E. Freise
- Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143 USA
| | - Nathan M. Bass
- Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143 USA
| |
Collapse
|
60
|
Papafragkakis H, Moehlen M, Garcia-Buitrago MT, Madrazo B, Island E, Martin P. A case of a ruptured sclerosing liver hemangioma. Int J Hepatol 2011; 2011:942360. [PMID: 21994877 PMCID: PMC3170855 DOI: 10.4061/2011/942360] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2010] [Accepted: 04/11/2011] [Indexed: 11/29/2022] Open
Abstract
Hemangiomas are the most common benign tumors found in the liver, typically asymptomatic, solitary, and incidentally discovered. Although vascular in nature, they rarely bleed. We report a case of a 52-year-old woman with a previously stable hemangioma who presented to our hospital with signs and symptoms indicative of spontaneous rupture. We review the literature, focusing on diagnosis and management of liver hemangiomas.
Collapse
Affiliation(s)
- Haris Papafragkakis
- Division of Hepatology, University of Miami Miller School of Medicine, 1500 NW 12th Avenue, Suite 1101, Miami, FL 33136, USA,*Haris Papafragkakis:
| | - Martin Moehlen
- Division of Hepatology, University of Miami Miller School of Medicine, 1500 NW 12th Avenue, Suite 1101, Miami, FL 33136, USA
| | - Monica T. Garcia-Buitrago
- Department of Pathology, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Holtz Building, Room 2042, Miami, FL 33136, USA
| | - Beatrice Madrazo
- Department of Radiology, University of Miami Miller School of Medicine, 1611 NW 12th Avenue, Miami, FL 33136, USA
| | - Eddie Island
- Miami Transplant Institute, University of Miami Miller School of Medicine, Highland Professional Building, 1801 NW 9th Avenue, 3rd Floor, Miami, FL 33136, USA
| | - Paul Martin
- Division of Hepatology, University of Miami Miller School of Medicine, 1500 NW 12th Avenue, Suite 1101, Miami, FL 33136, USA
| |
Collapse
|
61
|
Molins IG, Font JMF, Álvaro JC, Navarro JLL, Gil MF, Rodríguez CMF. Contrast-enhanced ultrasound in diagnosis and characterization of focal hepatic lesions. World J Radiol 2010; 2:455-62. [PMID: 21225000 PMCID: PMC3018553 DOI: 10.4329/wjr.v2.i12.455] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2010] [Revised: 12/20/2010] [Accepted: 12/26/2010] [Indexed: 02/06/2023] Open
Abstract
The extensive use of imaging techniques in differential diagnosis of abdominal conditions and screening of hepatocellular carcinoma in patients with chronic hepatic diseases, has led to an important increase in identification of focal liver lesions. The development of contrast-enhanced ultrasound (CEUS) opens a new window in the diagnosis and follow-up of these lesions. This technique offers obvious advantages over the computed tomography and magnetic resonance, without a decrease in its sensitivity and specificity. The new second generation contrast agents, due to their intravascular distribution, allow a continuous evaluation of the enhancement pattern, which is crucial in characterization of liver lesions. The dual blood supply in the liver shows three different phases, namely arterial, portal and late phases. The enhancement during portal and late phases can give important information about the lesion’s behavior. Each liver lesion has a different enhancement pattern that makes possible an accurate approach to their diagnosis. The role of emerging techniques as a contrast-enhanced three-dimensional US is also discussed. In this article, the advantages, indications and technique employed during CEUS and the different enhancement patterns of most benign and malignant focal liver lesions are discussed.
Collapse
|
62
|
|
63
|
Nikièma Z, Sawadogo A, Kyelem CG, Cissé R. [Hepatocellular carcinoma in rural Burkina Faso Africa: contribution of ultrasound, about 58 cases]. Pan Afr Med J 2010; 7:10. [PMID: 21918697 PMCID: PMC3172639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2010] [Accepted: 10/23/2010] [Indexed: 11/24/2022] Open
Abstract
Introduction Décrire les différents aspects échographiques de carcinome hépatocellulaire (CHC) et préciser l’apport de l’échographie dans le diagnostic des CHC dans le contexte burkinabè. Méthodes U+00C9tude prospective descriptive de 12 mois, réalisée dans les services de médecine interne et d’imagerie médicale du CHU Souro Sanou de Bobo Dioulasso, portant sur 58 patients ayant un CHC. Tous les patients ont bénéficié d’une exploration échographique abdominale et dans certains cas d’un dosage du taux d’alpha-foetoprotéine et d’un examen histologique hépatique. Les caractères échographiques des tumeurs et les signes extra tumoraux associés ont été notés. Résultats Cinquante huit patients d’âge moyen de 45,6 ±12,5 ans (extrêmes 22-77 ans), avec une nette prédominance masculine (n=44) étaient inclus dans l’étude. Le retard diagnostic était de plus de 3 mois dans 50,7%. L’échographie décrivait des grosses tumeurs (69% des cas), multinodulaires (67,2%), à majorité hyperéchogènes (70,7%). Cinq formes pseudo suppuratives étaient notées (8,7%). L’ascite (60,3% des cas) et la thrombose portale (56,8%) étaient les signes extra-tumoraux les plus fréquents. La thrombose cave inférieure (n=1) était rare. L’alpha-foetoprotéine était significativement élevée chez 10 patients (43,5%). L’examen histologique (n=20) décrivait un CHC chez 18 patients (90%). Conclusion Au Burkina Faso, le CHC est multinodulaire, hyperéchogène et de grosse taille avec une forme particulière pseudo abcédée. L’imagerie échographique est un examen complémentaire indispensable décrivant des aspects presque pathognomoniques du CHC. Toutefois, son association à l’histologie est plus utile que le dosage de l’alpha-foetoprotéine dans le diagnostic des CHC.
Collapse
Affiliation(s)
- Zakari Nikièma
- Service d'Imagerie Médicale, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso,Corresponding author: Zakari Nikièma, Service d'Imagerie Médicale, Centre Hospitalier Universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso 01, Tél:(+226) 70 72 59 54 / (+226) 78 84 85 81, Fax: (+226) 20 97 26 93, Burkina Faso
| | - Appolinaire Sawadogo
- Service d'Imagerie Médicale, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso
| | - Carole Gilberte Kyelem
- Service d'Imagerie Médicale, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso
| | - Rabiou Cissé
- Service d'Imagerie Médicale, Centre Hospitalier Universitaire Sourô Sanou, Bobo-Dioulasso, Burkina Faso
| |
Collapse
|
64
|
Zhang Z, Chen HJ, Yang WJ, Bu H, Wei B, Long XY, Fu J, Zhang R, Ni YB, Zhang HY. Infantile hepatic hemangioendothelioma: A clinicopathologic study in a Chinese population. World J Gastroenterol 2010; 16:4549-57. [PMID: 20857525 PMCID: PMC2945486 DOI: 10.3748/wjg.v16.i36.4549] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate whether the clinicopathologic features of infantile hemangioendothelioma (IHE) of the liver in a Chinese population are similar to the features observed in other races.
METHODS: The clinical data, radiological findings, histopathological changes and outcome of 12 cases of IHE diagnosed by the Department of Pathology, West China Hospital over the last 10 years were analyzed retrospectively. Immunohistochemical studies were carried out using antibodies against CD31, CD34, Factor VIII, cytokeratin 8 and cytokeratin 18.
RESULTS: The 12 patients were aged from fetal to 5 years (three males and nine females). The tumor was presented with different clinical manifestations, mainly as an asymptomatic, palpable, upper abdominal mass, except for the two fetuses who were detected antenatally by ultrasound. In one patient, this presentation was accompanied by an initial severe pneumothorax. No symptoms of congestive heart failure were present and neither congenital abnormalities nor vascular tumors in the skin or other organs were found. Laboratory abnormalities included leukocytosis (40%), anemia (60%), thrombocytosis (60%), hyperbilirubinemia (16.7%), abnormal liver function (50%) and increased α-fetoprotein (80%). Based on radiological findings and gross specimens, the tumor presented as a solitary lesion or a multifocal space-occupying lesion. The tumor size ranged from 5.0 cm × 3.5 cm × 2.0 cm to 13.8 cm × 9.0 cm × 7.7 cm, and the 0.2-1.1 cm nodules were diffusely distributed within the multifocal tumor. Seven cases were surgically resected, three cases underwent biopsy and the two fetuses were aborted. Histologically, nine cases were classified as type I and three as type II, presenting aggressive morphologic features, immature vessels, active mitosis and necrosis. An inflammatory component, predominantly eosinophilic granulocytes, sometimes obscured the nature of the tumor. Ten patients are alive after a follow-up of 1-9 years. Based on immunohistochemistry, the endothelial cells in all cases were positive for CD31, CD34 and polyclonal factor VIII antigen, whereas the scattered hyperplasia bile ducts were positive for cytokeratin 8 and cytokeratin 18.
CONCLUSION: The clinical manifestations of IHE are non-specific. There is no significant correlation between histological type and prognosis. The clinicopathologic features of IHE in Chinese patients may provide a clue to further evidence-based studies.
Collapse
|
65
|
|
66
|
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 2010; 195:13-28. [PMID: 20566794 DOI: 10.2214/ajr.10.4392] [Citation(s) in RCA: 250] [Impact Index Per Article: 17.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE The purpose of this article is to review the pharmacokinetic and pharmacodynamic properties of gadoxetate disodium (Gd-EOB-DTPA), to describe a workflow-optimized pulse sequence protocol, and to illustrate the imaging appearance of focal lesions in the noncirrhotic liver. CONCLUSION Gd-EOB-DTPA allows a comprehensive evaluation of the liver with the acquisition of both dynamic and hepatocyte phase images. This provides potential additional information, especially for the detection and characterization of small liver lesions. However, protocol optimization is necessary for improved image quality and workflow.
Collapse
|